Clinical trials show progress in migraine frequency, skin cancer prevention
-
1:19
Former Brewers owner Bud Selig reflects on bringing baseball...
-
2:20
Story Hill neighbors call for pedestrian safety as Brewers head...
-
3:00
CBS 58 Hometowns LIVE: Milwaukee County Zoo’s Spooky Safari
-
2:30
Brookfield woman who beat cancer twice surprised with Game 1...
-
2:04
Have you seen this dog? Minnesota couple asks Milwaukee community...
-
5:09
Visit Milwaukee preview: Oct. 23-25
-
1:34
O&H Bakery makes Pocket Kringle to celebrate World Series run
-
1:02
Versiti offers chance to win Brewers World Series tickets in...
-
3:20
Watch party tickets for World Series games 3 and 4 go on sale,...
-
5:47
CBS 58’s Theater Thursdays: ’You Can See Everything’ and...
-
4:31
👹 Meet ‘Morbid Paul’: The Kenosha artist bringing monsters...
-
2:10
NOAA winter outlook released as October continues to stay mild
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.